Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MALIGNANT PLEURAL MESOTHELIOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00797719
What this trial is testing

Short Neoadjuvant Hemithoracic IMRT for MPM

Who this might be right for
Malignant Pleural Mesothelioma
University Health Network, Toronto 104
Testing effectiveness (Phase 2)Study completedNCT00996567
What this trial is testing

Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

Who this might be right for
Cancer
University Hospital, Ghent 22
Early research (Phase 1)Ended earlyNCT05228015
What this trial is testing

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more
Ikena Oncology 67
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT01241682
What this trial is testing

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

Who this might be right for
Malignant (Pleural) Mesothelioma
Erasmus Medical Center 10
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)WithdrawnNCT03920839
What this trial is testing

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Who this might be right for
Advanced and/or Metastatic Solid TumorsStage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung CancerAdvanced/Metastatic Unresectable Malignant Pleural Mesothelioma
Incyte Corporation
Testing effectiveness (Phase 2)UnknownNCT05930665
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Sun Yat-sen University 38
Testing effectiveness (Phase 2)Ended earlyNCT00604461
What this trial is testing

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
H. Lee Moffitt Cancer Center and Research Institute 13
Early research (Phase 1)Study completedNCT00165555
What this trial is testing

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 70
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Not applicableUnknownNCT06410625
What this trial is testing

Evaluation of Response by FLT PET in Mesothelioma

Who this might be right for
Pleural MesotheliomaTreatment ResponseChemotherapy Effect
Ankara University 25
Testing effectiveness (Phase 2)Study completedNCT02139904
What this trial is testing

Vinorelbine in Mesothelioma

Who this might be right for
Mesothelioma
Wales Cancer Trials Unit 154
Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Large-scale testing (Phase 3)Study completedNCT01098266
What this trial is testing

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 400
Early research (Phase 1)Study completedNCT02959463
What this trial is testing

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Not applicableStudy completedNCT03537833
What this trial is testing

Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed

Who this might be right for
Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy
CHU de Reims 172
Testing effectiveness (Phase 2)Study completedNCT00030745
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 61
Early research (Phase 1)WithdrawnNCT04201145
What this trial is testing

Pembrolizumab + Defactinib In Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Raphael Bueno, MD
Next Page